Optimization aspects of carcinogenesis

Medical Hypotheses

Volumn 74, Issue 5, 2010, Pages 922-927

  Brutovsky, B ^a   Horvath, D ^b,c  

^a P J AFÁRIK UNIVERSITY   (Slovakia)

^b CENTRE DE BIOPHYSIQUE MOLÉCULAIRE   (France)

^c TECHNICAL UNIVERSITY OF KO ICE   (Slovakia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER GROWTH; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; CANCER THERAPY; CARCINOGENESIS; COLORECTAL CANCER; CONCEPTUAL FRAMEWORK; DNA DAMAGE; GENE MUTATION; GENETIC HETEROGENEITY; GENETIC VARIABILITY; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; MATHEMATICAL MODEL; MOLECULAR EVOLUTION; MUTATION RATE; PHENOTYPIC VARIATION; SAMPLING ERROR; SOLID TUMOR; STATISTICAL ANALYSIS;

ALGORITHMS; ARTIFICIAL INTELLIGENCE; HUMANS; MODELS, BIOLOGICAL; NEOPLASMS;

EID: 77950955062     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2009.10.019     Document Type: Article

References (56)

1. Hanahan D., Weinberg R.A. The hallmark of cancer. Cell 2000, 100:57-70.
2. Sjöblom T., Jones S., Wood L.D., et al. The consensus coding sequences of human breast and colorectal cancers. Science 2006, 314:268-274.
3. Kitano H. Cancer as a robust system: implications for anticancer therapy. Nat Rev Cancer 2004, 4:227-235.
4. Komarova N.L., Wodarz D. Evolutionary dynamics of mutator phenotypes in cancer: implications for chemotherapy. Cancer Res 2003, 63:6635-6642.
5. Witz I.P., Levy-Nissenbaum O. The tumor microenvironment in the post-Paget era. Cancer Lett 2006, 242:1-10.
6. Anderson A.R.A., Weaver A.M., Cummings P.T., Quaranta V. Tumor morphology and phenotypic evolution driven by selective pressure from microenvironment. Cell 2006, 127:905-915.
7. Ingber D.E. Can cancer be reversed by engineering the tumor microenvironment?. Semin Cancer Biol 2008, 18:356-364.
8. Heineman R.H., Bull J.J. Testing optimality with experimental evolution: Lysis time in bacteriophage. Evolution 2007, 61:1695-1709.
9. Chareyron S., Alamir M. Mixed immunotherapy and chemotherapy of tumors: feedback design and model updating schemes. J Theor Biol 2009, 258:444-454.
10. Komarova N.L., Sadovsky A.V., Wan F.Y. Selective pressures for and against genetic instability in cancer: a time-dependent problem. J R Soc Interface 2008, 5:105-121.
11. Holland JH. Adaptation in natural and artificial systems. The University of Michigan; 1975.
12. Morrison R.W. Designing evolutionary algorithms for dynamic environments 2004, Springer.
13. Bethke AD. Genetic algorithms as function optimizers (doctoral dissertation). University of Michigan; 1980.
14. Goldberg D.E. Construction of higher-order deceptive functions using low-order Walsh coefficients. An Math Artif Intel 1992, 5:35-48.
15. Beveridge G.S.G., Schechter R.S. Optimization: theory and practice 1970, McGraw-Hill.
16. Greaves M. Darwinian medicine: a case for cancer. Nat Rev Cancer 2007, 7:213-221.
17. Beerenwinkel N., Antal T., Dingli D., et al. Genetic progression and the waiting time to cancer. PLoS Comput Biol 2007, 3:e225.
18. Wood L.D., Parsons D.W., Jones S., et al. The genomic landscapes of human breast and colorectal cancers. Science 2007, 318:1108-1113.
19. Gatenby R.A., Frieden B.R. Information dynamics in carcinogenesis and tumor growth. Mutat Res 2004, 568:259-273.
20. Beer P.A., Jones A.V., Bench A.J., et al. Clonal diversity in the myeloproliferative neoplasms: independent origins of genetically distinct clones. Brit J Haematol 2009, 144:904-908.
21. Taniguchi K., Okami J., Kodama K., Higashiyama M., Kato K. Intratumor heterogeneity of epidermal growth factor receptor mutations in lung cancer and its correlation to the response to gefitinib. Cancer Sci 2008, 99:929-935.
22. Maley C.C., Galipeau P.C., Finley J.C., et al. Genetic clonal diversity predicts progression to esophageal adenocarcinoma. Nat Genet 2006, 38:468-473.
23. Greenman C., Stephens P., Smith R., et al. Patterns of somatic mutation in human cancer genomes. Nature 2007, 446:153-158.
24. Luo J., Solimini N.L., Elledge S.J. Principles of cancer therapy: oncogene and non-oncogene addiction. Cell 2009, 136:823-837.
25. Heng H.H.Q., Bremer S.W., Stevens J.B., Ye K.J., Liu G., Ye C.J. Genetic and epigenetic heterogeneity in cancer: a genome-centric perspective. J Cell Physiol 2009, 220:538-547.
26. Eigen M. Self-organization of matter and the evolution of biological macromolecules. Naturwiss 1971, 58:465-523.
27. Forster R., Wilke C.O. Tradeoff between short-term and long-term adaptation in a changing environment. Phys Rev E 2005, 72:041922.
28. Earl D.J., Deem M.W. Evolvability is a selectable trait. Proc Natl Acad Sci USA 2004, 101:11531-11536.
29. Tenaillon O., Toupance B., Nagard H.L., Taddei F., Godelle B. Mutators, population size, adaptive landscape and the adaptation of asexual populations of bacteria. Genetics 1999, 152:485-493.
30. Donaldson-Matasci M.C., Lachmann M., Bergstrom C.T. Phenotypic diversity as an adaptation to environmental uncertainty. Evol Ecol Res 2008, 10:493-515.
31. Goldberg D.E. Genetic algorithms in search, optimization, and machine learning 1989, Addison-Wesley.
32. Sabatier P.C. Inverse problems - an introduction. Inverse Probl 1985, 1:UL1.
33. Varshavsky A. Targeting the absence: homozygous dna deletions as immutable signposts for cancer therapy. Proc Nat Acad Sci USA 2008, 104:14935-14940.
34. Skordalakes E. Telomerase structure paves the way for new cancer therapies. Future Oncol 2009, 5:163-167.
35. Fidler I.J. Tumor heterogeneity and the biology of cancer invasion and metastasis. Cancer Res 1978, 38:2651-2660.
36. Futreal P.A., Coin L., Marshall M., et al. A consensus of human cancer genes. Nat Rev Cancer 2004, 4:177-183.
37. Kitano H. Tumour tactics. Nature 2003, 426:125.
38. Klein C.A., Blankenstein T.J.F., Schmidt-Kittler O., Petronio M., Polzer B., Stoecklein N.H. Genetic heterogeneity of single disseminated tumour cells in minimal residual cancer. Lancet 2002, 360:683-689.
39. Sole R.V., Deisboeck T.S. An error catastrophe in cancer?. J Theor Biol 2004, 228:47-54.
40. Cahill D.P., Kinzler K.W., Vogelstein B., Lengauer C. Genetic instability and darwinian selection in tumours. Trends Biochem Sci 1999, 24:M57-M60.
41. Maley C.C., Reid B.J., Forrest S. Cancer prevention strategies that address the evolutionary dynamics of neoplastic cells: Simulating benign cell boosters and selection for chemosensitivity. Cancer Epidemiol Biomark Prev 2004, 13:1375-1384.
42. Wilke C.O., Wang J.L., Ofria C., Lenski R.E. Evolution of digital organisms at high mutation rates leads to survival of the flattest. Nature 2001, 412:331-333.
43. Schneider B.L., Kulesz-Martin M. Destructive cycles: the role of genomic instability and adaptation in carcinogenesis. Carcinogenesis 2004, 25:2033-2044.
44. Folkman J., Bach M., Rowe J.W., et al. Tumor angiogenesis - therapeutic implications. New Engl J Med 1971, 285:1182-1186.
45. Bergers G., Hanahan D. Modes of resistance to antiangiogenic therapy. Nat Rev Cancer 2008, 8:592-603.
46. Paez-Ribes M., Allen E., Hudock J., et al. Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis. Cancer Cell 2009, 15:220-231.
47. Ebos J.M.L., Lee C.R., Cruz-Munoz W., et al. Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis. Cancer Cell 2009, 15:232-239.
48. Hegreness M., Shoresh N., Damian D., Hartl D., Kishony R. Accelerated evolution of resistance in multidrug environments. Proc Nat Acad Sci USA 2008, 105:13977-13981.
49. Kim J.J., Tannock I.F. Repopulation of cancer cells during therapy: an important cause of treatment failure. Nat Rev Cancer 2005, 5:516-525.
50. Brunet E., Rouzine I.M., Wilke C.O. The stochastic edge in adaptive evolution. Genetics 2008, 179:603-620.
51. Clune J., Misevic D., Ofria C., Lenski R.E., Elena S.F., Sanjuan R. Natural selection fails to optimize mutation rates for long-term adaptation on rugged fitness landscapes. PLoS Comput Biol 2008, 4:e1000187.
52. Nilsson M., Snoad N. Optimal mutation rates in dynamic environments. Bull Math Biol 2002, 64:1033-1043.
53. Tanaka M.M., Bergstrom C.T., Levin B.R. The evolution of mutator genes in bacterial populations: the roles of environmental change and timing. Genetics 2003, 164:843-854.
54. Travis J.M.J., Travis E.R. Mutator dynamics in fluctuating environments. Proc R Soc Lond B 2002, 269:591-597.
55. Grefenstette JJ. Evolvability in dynamic fitness landscapes: a genetic algorithm approach. In: Proceedings of 1999 congress on evolutionary computation 2009. IEEE Press; 1999, p. 2031-8.
56. Pepper J.W., Findlay C.S., Kassen R., Spencer S.L., Maley C.C. Cancer research meets evolutionary biology. Evol Appl 2009, 2:62-70.